InsiderClue
Insiders · Profile

AULIN SHERRY

Chief Financial Officer at Xenon Pharmaceuticals. Filing since 2 Sep 2022. CIK 0001862144

Company
Date
Role
Action
Shares
Amount
Of holding
XENE Xenon Pharmaceuticals Inc.
18 Dec 2024
Chief Financial Officer
Sold at will
18,709
$770.91K
100%
XENE Xenon Pharmaceuticals Inc.
2 Sep 2022
Chief Financial Officer
Sold, plan not stated
15,355
$607.60K
100%
2 decisions on file.